Onyx Healthcare Inc. (TPEX:6569)
Taiwan · Delayed Price · Currency is TWD 98.50
-2.50 (-2.48%)
At close: Feb 11, 2026
Onyx Healthcare Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,380 | 1,241 | 1,493 | 1,600 | 1,202 | 1,347 | |
Revenue Growth (YoY) | 6.70% | -16.85% | -6.71% | 33.16% | -10.80% | -9.15% |
Cost of Revenue | 914.93 | 784.98 | 936.72 | 1,128 | 838.03 | 883.3 |
Gross Profit | 465.18 | 456.28 | 556.14 | 472.31 | 363.73 | 464.01 |
Selling, General & Admin | 262.23 | 247.47 | 258.98 | 241.59 | 208.96 | 232.16 |
Research & Development | 121.36 | 118.32 | 79.36 | 86.67 | 79.35 | 68.64 |
Operating Expenses | 383.62 | 367.55 | 338.02 | 326.91 | 289.22 | 303.35 |
Operating Income | 81.57 | 88.73 | 218.12 | 145.39 | 74.51 | 160.66 |
Interest Expense | -4.64 | -4.36 | -3.68 | -3.56 | -2.63 | -0.48 |
Interest & Investment Income | 16.38 | 13.88 | 3.39 | 4.69 | 6.36 | 2.29 |
Earnings From Equity Investments | 66.12 | 67.1 | 62.87 | 62.94 | 50.19 | 33.9 |
Currency Exchange Gain (Loss) | -8.34 | 13.12 | -7.42 | 19.28 | -6.02 | -12.29 |
Other Non Operating Income (Expenses) | 5.28 | 18 | 19.85 | 25.41 | 18.57 | 14.67 |
EBT Excluding Unusual Items | 156.36 | 196.47 | 293.14 | 254.14 | 140.98 | 198.76 |
Gain (Loss) on Sale of Investments | -8.93 | 9.95 | 11.86 | -12.45 | -0.87 | 3.86 |
Gain (Loss) on Sale of Assets | - | - | - | 0.25 | - | - |
Other Unusual Items | 0.03 | -0.01 | 0.01 | 0.09 | -0.01 | - |
Pretax Income | 147.46 | 206.41 | 305 | 242.03 | 140.11 | 202.61 |
Income Tax Expense | 17.46 | 26.28 | 49.83 | 38.9 | 13.6 | 37.71 |
Earnings From Continuing Operations | 130 | 180.13 | 255.17 | 203.14 | 126.51 | 164.91 |
Minority Interest in Earnings | 0.44 | 0.79 | 0.09 | -0.18 | 1.04 | 2.17 |
Net Income | 130.44 | 180.91 | 255.26 | 202.96 | 127.55 | 167.08 |
Net Income to Common | 130.44 | 180.91 | 255.26 | 202.96 | 127.55 | 167.08 |
Net Income Growth | -28.50% | -29.13% | 25.77% | 59.12% | -23.66% | -30.20% |
Shares Outstanding (Basic) | 39 | 39 | 38 | 37 | 35 | 35 |
Shares Outstanding (Diluted) | 39 | 39 | 39 | 38 | 35 | 35 |
Shares Change (YoY) | 0.23% | 0.61% | 2.85% | 7.68% | -0.14% | 0.11% |
EPS (Basic) | 3.36 | 4.69 | 6.66 | 5.43 | 3.67 | 4.80 |
EPS (Diluted) | 3.34 | 4.65 | 6.60 | 5.39 | 3.65 | 4.77 |
EPS Growth | -28.84% | -29.54% | 22.41% | 47.62% | -23.50% | -30.27% |
Free Cash Flow | 180.27 | 117.53 | 282.91 | 149.84 | -277.64 | 179.82 |
Free Cash Flow Per Share | 4.62 | 3.02 | 7.31 | 3.98 | -7.95 | 5.14 |
Dividend Per Share | 4.000 | 4.000 | 4.348 | 4.348 | 3.479 | 4.348 |
Dividend Growth | -8.01% | -8.01% | - | 25.00% | -20.00% | 14.58% |
Gross Margin | 33.71% | 36.76% | 37.25% | 29.51% | 30.27% | 34.44% |
Operating Margin | 5.91% | 7.15% | 14.61% | 9.09% | 6.20% | 11.92% |
Profit Margin | 9.45% | 14.57% | 17.10% | 12.68% | 10.61% | 12.40% |
Free Cash Flow Margin | 13.06% | 9.47% | 18.95% | 9.36% | -23.10% | 13.35% |
EBITDA | 96.34 | 105.12 | 235.93 | 163.63 | 90.84 | 174.4 |
EBITDA Margin | 6.98% | 8.47% | 15.80% | 10.22% | 7.56% | 12.94% |
D&A For EBITDA | 14.78 | 16.4 | 17.81 | 18.24 | 16.33 | 13.74 |
EBIT | 81.57 | 88.73 | 218.12 | 145.39 | 74.51 | 160.66 |
EBIT Margin | 5.91% | 7.15% | 14.61% | 9.09% | 6.20% | 11.92% |
Effective Tax Rate | 11.84% | 12.73% | 16.34% | 16.07% | 9.71% | 18.61% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.